Fortis Capital Advisors LLC Raises Position in UnitedHealth Group Incorporated $UNH

Fortis Capital Advisors LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 59.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 619 shares of the healthcare conglomerate’s stock after purchasing an additional 230 shares during the period. Fortis Capital Advisors LLC’s holdings in UnitedHealth Group were worth $324,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Belpointe Asset Management LLC boosted its position in shares of UnitedHealth Group by 3.6% in the first quarter. Belpointe Asset Management LLC now owns 9,114 shares of the healthcare conglomerate’s stock worth $4,774,000 after purchasing an additional 315 shares during the period. Focus Partners Wealth boosted its position in shares of UnitedHealth Group by 5.3% in the first quarter. Focus Partners Wealth now owns 277,916 shares of the healthcare conglomerate’s stock worth $145,559,000 after purchasing an additional 14,112 shares during the period. Integrity Alliance LLC. boosted its position in shares of UnitedHealth Group by 376.4% in the first quarter. Integrity Alliance LLC. now owns 13,395 shares of the healthcare conglomerate’s stock worth $7,016,000 after purchasing an additional 10,583 shares during the period. Ransom Advisory Ltd bought a new position in shares of UnitedHealth Group in the first quarter worth approximately $469,000. Finally, Anchor Investment Management LLC boosted its position in shares of UnitedHealth Group by 2.5% in the first quarter. Anchor Investment Management LLC now owns 23,542 shares of the healthcare conglomerate’s stock worth $12,330,000 after purchasing an additional 570 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

UNH opened at $347.27 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $314.51 billion, a PE ratio of 15.05, a P/E/G ratio of 2.27 and a beta of 0.45. The firm has a 50 day moving average of $290.20 and a two-hundred day moving average of $371.22.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same period in the prior year, the business posted $6.80 earnings per share. The business’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.

Wall Street Analysts Forecast Growth

Several research firms have commented on UNH. TD Cowen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective for the company. in a research report on Monday, May 19th. Sanford C. Bernstein increased their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a report on Friday, September 5th. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $342.00 to $325.00 and set an “overweight” rating on the stock in a report on Wednesday, August 20th. Finally, Hsbc Global Res cut shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $355.77.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.